Knowledge discovery of patients reviews on breast cancer drugs: Segmentation of side effects using machine learning

Mehrbakhsh Nilashi1,2, Hossein Ahmadi3, Rabab Ali Abumalloh4

  • 1UCSI Graduate Business School, UCSI University, 56000, Cheras, Kuala Lumpur, Malaysia.

Heliyon
|October 21, 2024
PubMed

Insights

This study analyzed breast cancer drug reviews using machine learning to identify key patient experiences and side effects. Findings offer insights for patients choosing breast cancer medications.

Area of Science:

  • Oncology
  • Pharmacovigilance
  • Data Science

Background:

  • Breast cancer is a leading global health concern for women.
  • Understanding patient drug experiences is crucial for treatment optimization.
  • Patient reviews offer a valuable, yet underutilized, data source.

Purpose of the Study:

  • To apply machine learning for knowledge discovery in breast cancer drug reviews.
  • To identify key aspects of patient experiences and their relationship with drug effectiveness.
  • To categorize common side effects reported by breast cancer patients.

Main Methods:

  • Latent Dirichlet Allocation (LDA) for topic modeling of patient reviews.
  • Expectation-Maximization (EM) algorithm for data segmentation based on satisfaction.
  • Forward Entry Regression to correlate patient experiences with drug effectiveness.

Main Results:

  • Identified 8 primary categories of breast cancer drug side effects: Musculoskeletal, Menopausal, Dermatological, Metabolic, Gastrointestinal, Neurological/Cognitive, Respiratory, and Cardiovascular.
  • Established relationships between specific patient-reported experiences and perceived drug effectiveness within satisfaction segments.
  • Revealed patterns in patient feedback regarding breast cancer treatments.

Conclusions:

  • Machine learning effectively extracts valuable insights from patient reviews on breast cancer drugs.
  • The identified side effect categories provide a framework for understanding patient-reported adverse events.
  • Findings can empower patients to make more informed decisions about their breast cancer treatment options.